The 5-year incidence of myocardial infarction and claudication was examined in a group of middle-aged patients (n = 133, 70 men and 63 women) with newly diagnosed noninsulin-dependent diabetes and nondiabetic control subjects (n = 144, 62 men and 82 women). The effects of general risk factors, plasma insulin level, and lipoprotein abnormalities on the incidence of myocardial infarction and claudication were also evaluated by univariate analyses in both diabetic patients and nondiabetic subjects and by multivariate analyses combining both groups. The age-adjusted incidence of myocardial infarction was higher both in diabetic men (19.4%) and diabetic women (11.0%) than in nondiabetic men (3.2%,p=0.009) and nondiabetic women (3.0%6, p=0.047). Similarly, the age-adjusted incidence of claudication was higher among the diabetic patients (20.3% vs. 8.0% for men, p=0.06; 21.8% vs. 4.2% for women, p=0.003). None of the general risk factors (i.e., low density lipoprotein [LDL] cholesterol, blood pressure, smoking, and high density lipoprotein [HDL] cholesterol) showed an association with the risk of myocardial infarction either in the diabetic or nondiabetic groups of subjects, but an ischemic electrocardiographic abnormality at the baseline examination predicted myocardial infarction in diabetic men. In univariate analyses in diabetic subjects, high serum total cholesterol, low HDL cholesterol, high very low density lipoprotein (VLDL) cholesterol, and high total, LDL and VLDL triglycerides, and in nondiabetic subjects, high VLDL cholesterol and LDL triglycerides were associated with the appearance of claudication. In multivariate analyses including both diabetic and control subjects, only diabetes had an independent association with myocardial infarction, whereas smoking, high LDL triglycerides or VLDL cholesterol, and high fasting plasma insulin showed independent relations to claudication. The present results indicate that changes in lipoprotein composition characteristic of noninsulin-dependent diabetes are atherogenic and increase the risk of atherosclerotic vascular disease. Furthermore, high plasma insulin might also be involved in atherogenesis, independent of lipoprotein abnormalities.
small proportion of the excess occurrence of ASVD in diabetes can be explained by the effects of diabetes on general risk factors of ASVD,2,6-9 and other factors, for example, altered very low density lipoprotein (VLDL) catabolism products, low HDL cholesterol, and high plasma insulin levels, have been postulated to contribute to the excess occurrence of ASVD in NIDDM. [2] [3] [4] [5] 0l" Only a few prospective studies have been performed to research the relations of general risk factors to various vascular complications in patients with NIDDM in comparison with nondiabetic subjects,2,6-9 and even less is known about the effects of changes in lipoprotein composition on the incidence of ASVD. In the present study, we report the 5-year incidence of coronary heart disease and peripheral arterial disease in a group of patients with NIDDM followed up from diagnosis and in a comparable group of nondiabetic control subjects. 12-'4 In particular, the relations of various changes in lipoprotein composition characteristic of NIDDM and high fasting serum insulin level to the increased morbidity of peripheral ASVD among diabetic subjects were examined.
Methods Patients
The original study population consisted of 133 newly diagnosed patients with type II diabetes who were 45-64 years old at the time of diagnosis and 144 randomly selected nondiabetic subjects in the same age group, all of whom were investigated between May 1, 1979, and December 31, 1981 . Both groups were recruited from a defined area of 180,000 inhabitants in the county of Kuopio in Eastern Finland.
Diabetic patients. General practitioners working in community health centers and private practitioners in the survey area were asked to refer newly diagnosed diabetic patients with a fasting venous whole blood glucose level greater than or equal to 7.0 mmol/l and who were 45-64 years old to the outpatient department of Kuopio University Central Hospital. All patients were examined within 4 weeks after the detection of diabetes. Whenever necessary, those patients with hyperglycemic symptoms were admitted to the hospital immediately after diagnosis. The diagnosis of diabetes was confirmed by an oral glucose tolerance test using the diagnostic criteria recommended by the World Health Organization (WHO),15 that is, a fasting venous whole blood glucose level greater than or equal to 7.0 mmolI1, a 2-hour blood glucose level greater than or equal to 10 mmol/1, or both. Patients with secondary diabetes and those whose fasting blood glucose had exceeded 7.0 mmol/1 for more than 6 months were excluded. All patients were nonketotic at the time of diagnosis, and none needed insulin treatment during the followup period of at least 3 months from diagnosis. Of the 144 diabetic patients referred to the study, 11 were excluded. Five did not fulfill the diagnostic criteria of diabetes, one had hypothyroidism, three were outside the age limits, and two failed to complete the study. Thus, 133 patients with NIDDM were included in the study.
During the course of the study, it soon became evident that not all newly diagnosed diabetic patients fulfilling the criteria were being recruited into the study. This information was obtained from a separate survey in which all medical records of the health centers in 10 communities of the survey area were reviewed in 1980 for the identification of subjects with diabetes and for information concerning the time of diagnosis, diagnostic criteria, mode of treatment, and the prevalence of angina pectoris, hypertension, and congestive heart failure. 16 From these data, it could be estimated that approximately 30% of all diabetic subjects possibly eligible for the study had been recruited for the present study. As reported elsewhere in detail,12,17 the diabetic subjects included in the study did not differ significantly from those not included with respect to the prevalence of history of cardiovascular diseases or distribution by age and sex. In the study population, the age-adjusted prevalence of angina pectoris, hypertension, and congestive heart failure was 34.0%, 30.6%, and 26.5% for diabetic men and 25.5%, 55.2%, and 33.1% for diabetic women; the respective figures for those diabetic subjects not included were 29.3%, 38 .1%, and 31.4% for men and 25.2%, 45.7%, and 47.5% for women.
Control subjects. A random control population sample of subjects who were 45-64 years old was selected from the population registers of the study area, taking into consideration the distribution of the population living in rural and urban communities. Of 183 subjects originally contacted, nine had diabetes, one had hypothyroidism, and 29 refused to participate in the study. Thus, the final control population consisted of 144 nondiabetic subjects.
Study Population at 5-Year Examination
During the follow-up, eight diabetic patients (five men and three women) and two control subjects (one man and one woman) died. One diabetic man, three diabetic women, two control men, and four control women refused to participate in the 5-year study. Thus, 64 diabetic men, 57 diabetic women, 60 control men, and 77 control women were examined at the 5-year study ( Table 1) .
Baseline Examination
Medical history included a history of cardiovascular, renal, and any other significant long-term disease and the use of drugs. Chest pain symptoms suggestive of coronary heart disease (CHD) and history of claudication were recorded in an interview using the questionnaire developed by Rose.'8 Anthropometric measurements. Standing height was measured without shoes to the nearest 0.5 cm. Body weight was measured with an electric weighing machine (model 708, Seca, Hamburg, FRG) with the Blood pressure. With the patient or subject in the sitting position after a 5-minute rest, blood pressure was measured by one of the two specially trained nurses using a mercury sphygmomanometer (cuff size, 12.5 x 40.0 cm). Systolic and diastolic blood pressures were measured to the nearest 2 mm Hg. Disappearance of Korotkoff sounds (phase V) was used for diastolic blood pressure. Hypertension was diagnosed as a predetermined blood pressure level (systolic blood pressure 2160 mm Hg or diastolic blood pressure .95 mm Hg) and the history of antihypertensive drug treatment.
Resting electrocardiography. A conventional 12-lead resting electrocardiogram was recorded from each subject at both examinations and interpreted according to the Minnesota code (Mc).19
Classification for the diagnosis of coronary heart disease. Ischemic electrocardiographic abnormalities (Mc 1.1-3; 4.1-3, 5.1-3, and 7.1) included Q-QS abnormalities, various degrees of ST segment depression, T wave changes, and left bundle branch block. The definite myocardial infarction class consisted of patients with major Q-QS abnormalities (Mc 1.1-2), who had suffered from myocardial infarction verified at the hospital, or both. All the patient records were checked to verify the correct diagnosis of myocardial infarction.
Oral glucose tolerance test. At the baseline, an oral glucose tolerance test was performed after a 12-hour overnight fast. Samples for blood glucose and serum insulin determinations were taken before the test (fasting) and at 1 and 2 hours after glucose. Samples for serum insulin were placed in prechilled tubes, centrifuged, and stored without delay at -20°C until analyzed.
Blood glucose was analyzed by the glucose-oxidase method (Glox, Kabi Ab, Stockholm, Sweden). Serum insulin was analyzed by radioimmunoassay (antiserum M 8309, Novo Industries, Copenhagen, Denmark). The variation coefficient of the method was 5.4%, and sensitivity was 2 mU/l. Serum and lipoprotein lipids were determined from 12-hour fasting samples. Lipoproteins were separated by ultracentrifugation at d 1.006 to remove VLDL, followed by precipitation of the infranatant fraction by dextran sulfate and magnesium chloride.20 Enzymatic methods were used for the determination of cholesterol21 and triglycerides22 from whole serum, the top layer after ultracentrifugation of VLDL, and the supernatant after precipitation of HDL. Low density lipoprotein (LDL) was calculated as the difference between whole serum and the sum of VLDL and HDL. The intra-assay variation for total cholesterol, HDL cholesterol, and triglycerides was 1.26%, 0.95%, and 3.1%, respectively, and the interassay variation was 3.3%, 1.9%, and 5.2%, respectively.
5-Year Examination and Follow-up
At the 5-year examination, methods similar to those used at the baseline were used as often as possible. At the 5-year examination, glucose was determined by a glucose dehydrogenase method (Merck Diagnostica, Darmstadt, FRG). Only plasma glucose and glycosylated HbA1 data are used in this study. Glycosylated HbA1 (GHbA1) at the 5-year examination was determined by a column chromatography (Quick-Step Fast Hemoglobin Test System, Isolab, Akron, Ohio) after incubation in 0.9% saline solution for 12 hours.
Data on the 5-year incidence of ASVD concern the following end points: cardiovascular mortality, nonfatal myocardial infarction, new angina pectoris, and claudication. Subjects who suffered a myocardial infarction before the baseline examination and those who had claudication at the baseline were excluded from the incidence analysis of myocardial infarction and claudication, respectively. The methods used for the diagnosis of nonfatal end points were the same as those previously described for the baseline examination.
Statistical Analyses
The difference between the groups concerning continuous variables was analyzed by the Student's t test for unpaired samples or by analysis of variance. Whole serum triglycerides, VLDL triglycerides, and insulin were analyzed after logarithmic transformation. Age adjustment was performed by the direct standardization method using the 45-64-year-old Finnish male and female population in 1980 and in 1985 as the standard populations. The significance of differences between the adjusted rates was analyzed by a test of proportions based on standardized normal distribution. Multiple logistic analyses were performed on both sexes together, combining diabetic and nondiabetic groups to find the independent contribution of different variables to the development of myocardial infarction and claudication. All the results concerning continuous variables are given as the mean+SEM except age. Approval for the study had been given by the Ethical Committee of the University of Kuopio. Informed consent was given by all subjects studied. Table 2 gives the baseline data on clinical and laboratory characteristics in the diabetic and nondiabetic groups. Diabetic patients were more obese than nondiabetic subjects. No significant difference was found in the mean blood pressure levels between the two groups in either sex, but drug treatment for hypertension was more than twofold as common among diabetic patients than nondiabetic subjects. The mean fasting insulin was higher in both sexes of diabetic patients than in nondiabetic subjects. No consistent difference was found in serum total cholesterol or LDL cholesterol levels between diabetic and nondiabetic groups, but HDL cholesterol was lower and VLDL cholesterol higher among diabetic patients. Additionally, serum total triglycerides, and VLDL and LDL triglycerides were on average higher in the diabetic group, although some differences were not statistically significant when sexes were analyzed separately. The baseline concerning the prevalence of cardiovascular diseases, cardiovascular drug treatment, blood pressure, insulin secretion capacity, and serum and lipoprotein lipids have been published in detail previously. [10] [11] [12] At the 5-year examination, 36 (56%) diabetic men and 23 (40%) diabetic women were treated with diet only, and 27 (42%) diabetic men and 30 (52%) diabetic women were on oral drugs. Insulin treatment had been started in one man (2%) and four women (7%).
Results

Clinical Characteristics
On average, the metabolic control at the 5-year examination was rather poor in both diabetic men and diabetic women ( Table 2 ). The mean fasting plasma glucose levels were 11.5 ±0.5 mmol/l for men and 12.4±+0.5 mmol/l for women. The respective values in nondiabetic subjects were 5.5+±0.1 mmol/l for men and 5.5 ±0.1 mmol/l for women. Seven of the nondiabetic men and six of the nondiabetic women had developed diabetes during the follow-up period, and they were excluded from the results concerning the metabolic data at the 5-year examination.
Similarly to the baseline examination, both diabetic men (28.4+0.5 kg/M2) and diabetic women (28.8+±0.7 kg/M2) showed a higher body mass index than nondiabetic men (26.4±0.4 kg/m2,p<0.01) and nondiabetic women (27.2+0.6 kg/m2), although at the 5-year examination, the difference was not statistically significant in women.
Prevalence and Incidence of Atherosclerotic Vascular Disease
The prevalence of coronary heart disease by different criteria was at the diagnosis more common in both sexes of diabetic patients than in control sub- jects (Table 3 ). There was no significant difference in the prevalence of claudication at the baseline examination. At the baseline examination, one diabetic man, one nondiabetic man, three diabetic women, and one nondiabetic woman had suffered from definite or possible stroke. Altogether, eight diabetic patients (five men and three women) and two nondiabetic control subjects (one man and one woman) died during the follow-up period. Cardiovascular disease was a cause of death in four of the diabetic men, all of them dying from coronary heart disease, and cardiovascular disease was also a cause of death in one nondiabetic man and two diabetic women.
The incidence of myocardial infarction during the follow-up was sixfold in diabetic men and 3.7-fold in diabetic women compared with the nondiabetic control subjects. Also, the incidence of angina pectoris tended to be higher in diabetic patients than in control subjects ( Table 3 ). The incidence of claudication was higher in both diabetic men (20.3% vs. 8.0%, p=0.06) and diabetic women (21.8% vs. 4.2%,p=0.003) than in nondiabetic men and women. The incidence of stroke was three of 69 (4%) for diabetic men, one of 61 (2%) for nondiabetic men, two of 60 (3%) for diabetic women, and one of 81 (1%) for nondiabetic women. Table 4 shows coronary heart disease mortality and morbidity in relation to baseline ischemic electrocar-diographic abnormalities in diabetic patients and control subjects. In diabetic men, the occurrence of ischemic electrocardiographic abnormalities predicted the future coronary heart disease mortality and nonfatal myocardial infarction, however, in diabetic women, this association was not found.
Relation of 5-Year Incidence ofAtherosclerotic Vascular Disease to the Baseline Electrocardiographic Findings and Risk Factors
No significant associations between serum or lipoprotein lipids and the incidence of myocardial infarction were observed either in diabetic patients or nondiabetic subjects (Table 5 ).
Serum total cholesterol was significantly higher in diabetic patients with new claudication than in those without claudication. This difference could be ascribed to the higher VLDL cholesterol level in patients who developed claudication because patients with claudication did not differ from those without claudication with respect to LDL cholesterol levels. The HDL cholesterol level tended to be lower in patients with claudication than in those without claudication, but the difference did not reach statistical significance (p=0.078) after taking age and body mass index into consideration. Serum total triglycerides and VLDL and LDL triglycerides were significantly higher in diabetic patients with claudication than in those without claudication. In nondiabetic subjects, serum total cholesterol tended to be higher in patients with claudication than in those without claudication, and similarly to diabetic patients, patients with claudication showed elevated VLDL cholesterol and LDL triglyceride levels (Table 6 ). Body mass index and blood glucose, as well as fasting or postglucose serum insulin levels determined at the baseline did not show significant associations with the incidence of myocardial infarction in any subgroup (data not shown). Fasting blood glucose determined either at the baseline or at the 5-year examination or GHbA1 at the 5-year examination did not associate with claudication, and neither did body mass index. Fasting serum insulin, even after adjustment for age and body mass index, was significantly higher in diabetic men and women with claudication than in those without claudication (Table 6 ). One-hour and 2-hour postglucose serum insulin levels also tended to be higher in diabetic subjects with claudication (data not shown). No significant association between fasting insulin and claudication was observed in nondiabetic subjects, although a trend to higher plasma insulin was observed in subjects with claudication.
Smoking at the baseline examination showed no significant relation to myocardial infarction during the follow-up in any subgroup, but smoking was more TAge-adjusted prevalence. common in diabetic men with claudication than in those without claudication. Smoking showed also an association with claudication in control men, but due to the small number of incidence cases, the level of statistical significance (p=0.09) was not reached ( Table 6 ). The level of systolic or diastolic blood pressure at the baseline or the occurrence of hypertension did not predict myocardial infarction either in diabetic or nondiabetic subjects (Table 7) . Systolic and diastolic blood pressure levels were significantly higher in diabetic subjects with new claudication than in those without claudication.
The occurrence of hypertension showed no significant relation with claudication in diabetic subjects. In the control group, no significant associations were found between blood pressure levels or the occurrence of hypertension and the incidence of claudication ( Table 7) .
Multiple Logistic Analyses of the Relations Between Myocardial Infarction or Claudication and Risk Factors and Different Lipoproteins
In multiple logistic analyses of the relation of myocardial infarction to various risk factors (shown in Table 8 ) in the total study population, only diabetes showed an independent effect (t=2.55, p<O.01). Table 8 shows the results concerning multiple logistic analysis of the relations between claudication and selected lipoproteins and other risk factors. According to different analyses performed, it became evident that in addition to smoking (at the baseline), LDL triglycerides showed the strongest association with claudication. When VLDL cholesterol was included instead of LDL triglycerides, it also had a significant independent relation to claudication (t=2.70, p<0.01), whereas the effect of VLDL triglycerides was not significant. High fasting insulin also predicted the development of claudication. The impact of LDL cholesterol was less consistent, and HDL cholesterol had no significant association in these analyses. The impact of diabetes also remained nonsignificant. When multiple logistic analyses were performed separately in diabetic and nondiabetic groups, LDL triglycerides showed an independent association with claudication in both groups.
Discussion
The main findings of this prospective study on the incidence of atherosclerotic vascular disease in a representative group of newly diagnosed middleaged patients with NIDDM and nondiabetic control subjects were a more than fourfold excess incidence of coronary heart disease and a 2.5-5-fold excess incidence of peripheral arterial disease among diabetic patients. Furthermore, a relation of peripheral arterial disease to lipoprotein abnormalities, reflecting a disturbed VLDL metabolism, was noted. An essential question in the interpretation of the present results is the selection of the study population. All the diabetic patients fulfilled the WHO criteria for diabetes mellitus15 at the baseline examination, and at the 5-year examination, they were mostly being treated with diet only or oral antidiabetic agents except for five who were receiving insulin. Additionally, 97% of our diabetic patients showed well-preserved insulin secretion capacity23 based on C-peptide measurement in an oral glucose tolerance test or after glucagon stimulation,24 thus confirming their correct classification to the groups of patients with NIDDM. Our study population comprised approximately 30% of all patients with newly diagnosed NIDDM in the 45-64-year-old age group in whom this diagnosis was made during the baseline study period in the study area. We were able to confirm by a separate survey16 that the group of diabetic patients included in our study cohort was well representative of all newly diagnosed diabetic patients in this age group.12,17 There does not therefore appear to be any indication for selective bias in the formation of the diabetic study group. Our results on the higher frequency of myocardial infarction in both sexes of diabetic patients is consistent with previous prospective studies in various study populations using different criteria for dia-betes1'2,6-9 and a large cross-sectional study performed in East and West Finland showing a pronounced excess prevalence of coronary heart disease among diabetic subjects. 25 In the present study, none of the risk factors examined except diabetes itself had a significant relation to the incidence of myocardial infarction during the follow-up study. This finding is in contrast to previous prospective studies showing that the effect of known cardiovascular risk factors on cardiovascular morbidity is similar in diabetic patients and nondiabetic subjects.2'6-9 The present finding does not mean, however, that general risk factors, for example, elevated serum total and LDL cholesterol, high blood pressure, and smoking, have not contributed to the coronary atherosclerosis in the diabetic patients in the present study. The lack of association of risk factors with the incidence of coronary heart disease events in the present study might be due to the fact that coronary heart disease was already so frequent and severe at the diagnosis of our diabetic patients.12 Furthermore, factors like increased susceptibility to thrombus formation and some other factors related to the diabetic status itself3'26 might have had a central role in precipitating myocardial infarction in patients with either asymptomatic or symptomatic coronary heart disease. In fact, the only factor that showed an association with myocardial infarction was an ischemic electrocardiographic change in diabetic men at the baseline, whereas in diabetic women, even this association could not be noted. The lack of association could also be explained by the small number of patients with new myocardial infarction. Additionally, attempts to reduce risk factors might have played a role because diabetic subjects were effectively treated for hypertension, and they also had received dietary advice to reduce saturated fat and cholesterol intake. Stopping smoking was also particularly common among diabetic patients.
Information concerning the incidence of intermittent claudication in diabetic patients compared with nondiabetic subjects is available from only two prospective population studies. In the Framingham Study, based on the 20-year follow-up, the incidence was 3.8-fold higher in diabetic men and 6.0-fold higher in diabetic women than in the respective nondiabetic subjects.7 During the 5-year follow-up of the Israel Ischaemic Heart Disease study in the male population, the incidence of intermittent claudication was 2.2-fold higher in previously diagnosed diabetic patients and 2.3-fold higher in newly diagnosed diabetic patients than in nondiabetic subjects.27 These figures are in accordance with our results, that is, diabetic men showing 2.5-fold and diabetic women showing 5.2-fold higher incidence of claudication compared with the respective control subjects.
In contrast to coronary heart disease, which has not been shown to relate to the known duration of NIDDM,1"2 the occurrence of peripheral arterial disease in diabetic patients is associated with the duration of diabetes.2 This was evident also in the present study because there was no clear excess of claudication in diabetic patients at the diagnosis; however, at 5-year examination, diabetic patients of both sexes showed a markedly higher incidence of claudication compared with nondiabetic subjects. The method used for the diagnosis of peripheral arterial disease can be criticized. Claudication history, however, has been shown to have high specificity and positive predictive value but its sensitivity is low for large vessel peripheral arterial disease.28 This might lead to underestimation of the true occurrence of peripheral arterial disease.
At the time of diagnosis, the diabetic patients showed a lipid pattern typical for NIDDMM,2-5'14 that is, there was an increase in serum and VLDL triglycerides and a decrease in HDL cholesterol compared with nondiabetic control subjects. Furthermore, VLDL cholesterol and LDL triglyceride levels were elevated in diabetic patients. These changes indicate an altered composition of VLDL particles.4'5 Similar lipid and lipoprotein abnormalities have been reported previously by others.29-32 Based on a limited number of cross-sectional and prospective studies, both total serum triglycerides or VLDL triglycerides,33-39 and low HDL cholesterol38'39 have been shown to be related to claudication or otherwise defined peripheral vascular disease. In the crosssectional results of the WHO Multinational Study, however, serum total triglyceride levels were not related to the prevalence of peripheral vascular disease, although they showed an association with myocardial infarction.40 In another prospective study, high serum triglycerides showed an independent association with major macrovascular complications including death, gangrene, and myocardial infarction in diabetic patients.41 Furthermore, results from the 11-year follow-up of the Paris Prospective Study showed that hypertriglyceridemia was the only factor that in multiple regression analysis was associated with coronary mortality in subjects with impaired glucose tolerance or diabetes.42 HDL cholesterol, however, was not included among the baseline data of the Paris Prospective Study.
Interestingly, we found that VLDL triglycerides, VLDL cholesterol, and LDL triglycerides showed a relation to the incidence of intermittent claudication both in diabetic patients and nondiabetic subjects, whereas the association between LDL cholesterol or HDL cholesterol and claudication was not so clear. Due to the few incidences of claudication, the relations of some lipoproteins, plasma insulin, and smoking did not reach the level of statistical significance in nondiabetic subjects. The findings concerning the predictive value of these risk factors, however, were consistent in both groups, and thus multiple regression analyses were performed, combining diabetic and nondiabetic subjects. In multiple logistic analyses, the independent effect of LDL triglycerides and VLDL cholesterol was significant, but HDL cholesterol showed no significant relation to claudication. Diabetes showed no significant association in multiple logistic analysis either. It should be emphasized, however, there are complex biologic and statistical interrelations between blood pressure, insulin level, HDL cholesterol, and triglycerides, and these interrelations were also found in our study subjects.14 Therefore, the results of multiple logistic analyses should be interpreted cautiously.
Nevertheless, in accordance with findings from experimental studies, our results indicate that LDL enriched with triglycerides,43 and VLDL remnants or IDL arising during catabolism of VLDL to IDL and LDL are atherogenic4,44,45 and causally associated with the development of peripheral ASVDs in NIDDM.
Another interesting finding was the relation between high fasting serum insulin level and claudication. There is evidence coming from epidemiological,46-48 clinical,13,33,49,50 and experimental studies11 that high plasma insulin might be atherogenic and increase particularly the risk of coronary heart disease. Our results are compatible with this hypothesis, but the possibility that high fasting serum insulin could only be a reflection of insulin resistance and associated metabolic abnormalities that could also be related to atherogenesis cannot be ruled out. Insulin, however, might directly stimulate the proliferation of arterial smooth muscle cells,51 and recently, insulin has been shown to down-regulate high density lipoprotein receptors in human fibroblasts. Thus, an additional explanation is available for the link between insulin and atherogenesis. 52 In previous studies based on the large diabetic and nondiabetic populations, general cardiovascular risk factors have explained only a small proportion of the excess of ASVD in diabetic subjects1"26-9; however, these studies have been mainly confined to coronary heart disease mortality and morbidity, and they have not included all those lipoprotein fractions that might be relevant with respect to atherogenesis. Our results suggest that serum total or VLDL triglyceride levels are poor indicators of abnormalities in the metabolism of triglyceride-rich lipoprotein related to atherogenesis. Compatible with other studies,2 smoking showed an association with claudication, whereas obesity was not related to ASVD.
Both the incidence of myocardial infarction and intermittent claudication were substantially increased in patients with newly diagnosed NIDDM compared with control subjects. Abnormalities in lipoprotein composition, reflecting altered VLDL metabolism, and high fasting serum insulin showed an independent relation to the intermittent claudication, indicating that they contribute to the development of atherosclerosis.
